Drug Database
Back to search

United States· US:0220-0606_253c9d92-7556-4429-e063-6394a90a52f1

Artemisia vulgaris

A medicinal product containing artemisia vulgaris root, registered in United States by Boiron.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedArtemisia vulgarisATC—REGISTER NO.US:0220-0606_253c9d92…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about artemisia vulgaris rootAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ARTEMISIA VULGARIS ROOT
Manufacturer
Boiron
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0220060641
    200 [kp_C] in 1 TUBE (0220-0606-41)
  • ndc11
    0220-0606-41

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Artemisia vulgaris root in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All artemisia vulgaris root products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Czechia · Soluprick Sq
  • Germany · Alk-Prick Sq, Gemeiner Beifuß Hal Allergy
  • Denmark · Soluprick Sq
  • Finland · Soluprick Sq
  • United Kingdom (Northern Ireland) · Soluprick Sq
  • Netherlands · Soluprick Sq
  • Poland · Bylica Pospolita Prick Test Hal Allergy
  • Sweden · Soluprick Sq
  • Slovakia · Soluprick

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a2632e38-8fe6-4ac1-b744-91a7f69265c2
GET /v1/drugs/a2632e38-8fe6-4ac1-b744-91a7f69265c2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "200",
  "substance": "ARTEMISIA VULGARIS ROOT",
  "productndc": "0220-0606",
  "dosage_form": "PELLET",
  "dea_schedule": null,
  "strength_unit": "[kp_C]/200[kp_C]",
  "application_number": null,
  "marketing_category": "UNAPPROVED HOMEOPATHIC"
}
API referenceMCP serverPlans

See everything about artemisia vulgaris root.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console